- Messages
- 8,934
- Type of diabetes
- Type 1
- Treatment type
- Other
I understand that the way that pumps are used is to provide a basal insulin which is set up on an hourly or similarly periodic basis, plus boluses as and when necessary, with the added capability to vary the duration and amount of bolus that is done dependent on food type.
As was quoted in a different topic, pumps are really only an insulin administration device. Thinking about this made me wonder whether there is room for a cross between MDI and pump therapy. A kind of Hybrid Theory if you will (sorry Linkin Park).
I may be totally wrong here, and if I am I apologise, but it seems to me that pump therapy is really an extension of MDI, in as much as you replace the Basal insulin with pump maintained basal rate. Bolusing is more or less the same, and if you are undertaking dynamic management or intensive management, you are probably mimicking pump functions with MDI (multi-wave boluses, etc).
The question I was asking myself was whether there is room for a hybrid model which uses something like Tresiba to deliver a background insulin (potentially at a lower level than if it was your only basal) with the pump providing a level of basal on top, plus the flexibility around bolusing and dealing with things like Dawn Phenomenon.
I know it's not a normal therapy approach, but it struck me that it may provide a level of protection from sudden spikes in BG levels when there are issues with the pump, giving a level of protection (and maybe comfort) against DKA, while retaining the flexibility that a pump provides to cover DP and the unusual reactions to some food types.
Apologies if this is the wrong place to post this, but I thought it quite an interesting thought experiment.
As was quoted in a different topic, pumps are really only an insulin administration device. Thinking about this made me wonder whether there is room for a cross between MDI and pump therapy. A kind of Hybrid Theory if you will (sorry Linkin Park).
I may be totally wrong here, and if I am I apologise, but it seems to me that pump therapy is really an extension of MDI, in as much as you replace the Basal insulin with pump maintained basal rate. Bolusing is more or less the same, and if you are undertaking dynamic management or intensive management, you are probably mimicking pump functions with MDI (multi-wave boluses, etc).
The question I was asking myself was whether there is room for a hybrid model which uses something like Tresiba to deliver a background insulin (potentially at a lower level than if it was your only basal) with the pump providing a level of basal on top, plus the flexibility around bolusing and dealing with things like Dawn Phenomenon.
I know it's not a normal therapy approach, but it struck me that it may provide a level of protection from sudden spikes in BG levels when there are issues with the pump, giving a level of protection (and maybe comfort) against DKA, while retaining the flexibility that a pump provides to cover DP and the unusual reactions to some food types.
Apologies if this is the wrong place to post this, but I thought it quite an interesting thought experiment.